Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Luis Alberto García Rodríguez"'
Autor:
Luis Alberto García Rodríguez, Montse Soriano-Gabarró, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ana Ruigomez, Leif Friberg, Ron Herings, Karin M A Swart, Tania Schink, Elisabeth Smits, Annemarie Voss, Christine Tarenz, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Objectives To describe opportunities and challenges experienced from the four pharmacoepidemiological database studies included in the rivaroxaban post authorisation safety study (PASS) programme and propose ways to maximise the value of population-b
Externí odkaz:
https://doaj.org/article/71cd625a0f2244c3a4bb82474e3418be
Autor:
Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0298596 (2024)
BackgroundThe European rivaroxaban post-authorization safety study evaluated bleeding risk among patients initiated on rivaroxaban or vitamin K antagonists for the treatment and secondary prevention of venous thromboembolism in routine clinical pract
Externí odkaz:
https://doaj.org/article/21563d3bc5d248d7917f16c59b0f6158
Autor:
Luis Alberto García Rodríguez, Pareen Vora, Luke Roberts, Gunnar Brobert, Samuel Fatoba, María Eugenia Sáez, Antonio González-Pérez
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/32d4d86ecd8e4df7aa2725edd2fc8029
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16780 (2011)
Recent clinical trials and observational studies have reported increased coronary events associated with non steroidal anti-inflammatory drugs (NSAIDs). There appeared to be a disproportionate increase in non-fatal versus fatal events, however, numbe
Externí odkaz:
https://doaj.org/article/278c6c3152254d39901ad50eb32206de
Publikováno v:
PLoS Medicine, Vol 4, Iss 5, p e157 (2007)
BackgroundSuppression of prostacyclin (PGI2) is implicated in the cardiovascular hazard from inhibitors of cyclooxygenase (COX)-2. Furthermore, estrogen confers atheroprotection via COX-2-dependent PGI2 in mice, raising the possibility that COX inhib
Externí odkaz:
https://doaj.org/article/e2744e61fc8c4edd98d74d44fa150e40
Autor:
Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink, Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Kiliana Suzart-Woischnik, Gunnar Brobert, Ron M. C. Herings
Publikováno v:
García-Rodríguez, L A, Ruigómez, A, Schink, T, Voss, A, Smits, E, Swart, K M A, Balabanova, Y, Suzart-Woischnik, K, Brobert, G & Herings, R M C 2023, ' Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation : analysis of routine clinical data from four countries ', Expert opinion on drug safety . https://doi.org/10.1080/14740338.2023.2181334
Expert opinion on drug safety. Taylor and Francis Ltd.
Expert opinion on drug safety. Taylor and Francis Ltd.
Background: The safety and effectiveness of rivaroxaban versus vitamin K antagonists (standard of care [SOC]) for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) was evaluated in Europe. Research design and methods: Observat
Autor:
Daniel Albjerg Rudolph, Stine Munk Hald, Luis Alberto García Rodríguez, Sören Möller, Jesper Hallas, Larry B. Goldstein, David Gaist
Publikováno v:
Neurology. 99:e711-e719
Background and ObjectivesA causal relationship between long-term statin use and the risk of intracerebral hemorrhage (ICH) remains uncertain. We investigated the association with statin use before hospital admission for ICH in a Danish population–b
Autor:
Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
Background The European rivaroxaban post-authorization safety study evaluated bleeding risk among patients initiated on rivaroxaban or vitamin K antagonists for the treatment and secondary prevention of venous thromboembolism in routine clinical prac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc0803de5229a790f8e984c72eae187e
https://doi.org/10.21203/rs.3.rs-2664836/v1
https://doi.org/10.21203/rs.3.rs-2664836/v1
Autor:
Nils Jensen Boe, Stine Munk Hald, Mie Micheelsen Jensen, Jonas Asgaard Bojsen, Mohammad Talal Elhakim, Sandra Florisson, Alisa Saleh, Anne Clausen, Sören Möller, Frederik Severin Gråe Harbo, Ole Graumann, Jesper Hallas, Luis Alberto García Rodríguez, Rustam Al-Shahi Salman, Larry B. Goldstein, David Gaist
Publikováno v:
Neurology
BACKGROUND AND OBJECTIVES: A causal relationship between statin use and intracerebral hemorrhage (ICH) is uncertain. We hypothesized that an association between long-term statin exposure and ICH risk might vary for different ICH locations. METHODS: W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4364be3460ebcf0ab0e6eb4532e04db9
https://europepmc.org/articles/PMC9990851/
https://europepmc.org/articles/PMC9990851/
Autor:
David Gaist, Stine Munk Hald, Luis Alberto García Rodríguez, Anne Clausen, Sören Möller, Jesper Hallas, Rustam Al-Shahi Salman
Publikováno v:
Gaist, D, Hald, S M, García Rodríguez, L A, Clausen, A, Möller, S, Hallas, J & Al-Shahi Salman, R 2022, ' Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events ', JAMA Network Open, vol. 5, no. 10, pp. e2234215 . https://doi.org/10.1001/jamanetworkopen.2022.34215
ImportancePatients with stroke due to nontraumatic (spontaneous) intracerebral hemorrhage (ICH) often harbor vascular risk factors and comorbidities, but it is unclear which major adverse cardiovascular events (MACEs) occur more frequently among pati